Skip to main content

Advertisement

SpringerLink
Log in

Breast cancer hormone receptor status in Egypt: are we asking the questions that matter most?

  • Invited commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 23 June 2009

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M et al. (2009) Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat. doi:10.1007/s10549-009-0427-9

  2. Chopra R (2001) The Indian scene. J Clin Oncol 19(Suppl 18):106S–111S

    CAS  PubMed  Google Scholar 

  3. Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES et al (2008) Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 113(Suppl 8):2244–2256

    Article  PubMed  Google Scholar 

  4. Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Cancer 110(4):876–884

    Article  PubMed  Google Scholar 

  5. Anderson WF, Chu KC, Chatterjee N, Brawley O, Brinton LA (2001) Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. J Clin Oncol 19(1):18–27

    CAS  PubMed  Google Scholar 

  6. Li CI, Daling JR, Malone KE (2003) Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21(1):28–34

    Article  CAS  PubMed  Google Scholar 

  7. Shyyan R, Sener SF, Anderson BO, Garrote LM, Hortobagyi GN, Ibarra JA Jr et al (2008) Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer 113(Suppl 8):2257–2268

    Article  PubMed  Google Scholar 

  8. Early Breast Cancer Trialists’ Collaborative Group (2001) Tamoxifen for early breast cancer. Cochrane Database Syst Rev (1):CD000486. doi:10.1002/14651858.CD000486

Download references

Author information

Authors and Affiliations

  1. Breast Health Global Initiative, Fred Hutchinson Cancer Research Center, Seattle, USA

    Benjamin O. Anderson

  2. Department of Surgery, University of Washington, Box 356410, Seattle, WA, 98195, USA

    Benjamin O. Anderson

Authors
  1. Benjamin O. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin O. Anderson.

Additional information

This is a comment to doi:10.1007/s10549-009-0427-9.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, B.O. Breast cancer hormone receptor status in Egypt: are we asking the questions that matter most?. Breast Cancer Res Treat 120, 161–163 (2010). https://doi.org/10.1007/s10549-009-0474-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0474-2

Keywords

Search

Navigation